Skip to main content
All lobbying filings

SPLITOAK STRATEGIES LLC

SPLITOAK STRATEGIES LLC filed a Q3 report for ALKERMES, INC. on October 19, 2026, reporting $60,000 in lobbying income.

Lobbying for ALKERMES, INC. · Global biopharmaceutical company

All filings by SPLITOAK STRATEGIES LLC · Everything ALKERMES, INC. has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • SARAH KUEHL EGGE
    Previously held: Sarah: 1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (Kent Conrad); Fall 2011, Deputy Staff Director, Joint Select Committee for Deficit Reduction

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Medicare/Medicaid

Advance the use and funding of FDA-approved medicines to treat serious mental illness; protecting patient access to mental health medications in public programs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem